Table 1.
The baseline demographics and the study characteristics.
| Characteristic | (n = 191) |
|---|---|
| Age (years, mean ± SD) | 52.3 ± 12.2 (range 35 to 90) |
| Sex (Female, %) | 95 |
| Observation period (years, mean ±SD) | 5.4 ± 3.1 (range 2.0 to 14.1) |
| Ocular Surface Inflammation period (%) | 17.8, of entire observational period (29.1, of treatment plans) |
| Corneal Staining Score * (%) | |
| Grade 1 | 20.1 |
| Grade 2 | 46.0 |
| Grade 3 | 33.9 |
| The Symptom Scale (%) | |
| Satisfactory | 18.5 |
| Poor | 53.8 |
| Very poor | 27.7 |
* based on the quantitative ocular grading system by the Sjögren’s International Collaborative Clinical Alliance (SICCA).